About Universitätsklinikum Magdeburg
Im Universitätsklinikum Magdeburg A.ö.R. sind rund 4.100 Mitarbeiter in über 20 Instituten und 25 Kliniken tätig. Es ist mit etwa 1.100 Planbetten das größte Krankenhaus Magdeburgs und im nördlichen Sachsen-Anhalt. Der derzeitige Ärztliche Leiter des Universitätsklinikums ist Hans-Jochen Heinze.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Ulm
11
German CLL Study Group
9
Boehringer Ingelheim
5
German High-Grade Non-Hodgkin's Lymphoma Study Group
5
AGO Study Group
4
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany
4
Boston Scientific Corporation
3
Celgene
3
Cook Group Incorporated
3
Daiichi Sankyo, Inc.
3
European Organisation for Research and Treatment of Cancer - EORTC
3
Clinical Trials at Universitätsklinikum Magdeburg
During the past decade, Universitätsklinikum Magdeburg conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 29 clinical trials were completed, i.e. on
average, 43.3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 14 clinical trials were completed. i.e. 70%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Men With Germ Cell Cancer
1998-10-01
Unknown status
498
Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer
1999-12-01
2006-08-01
Completed
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
2000-09-01
Unknown status
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
1997-05-01
2002-02-01
Completed
Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
2001-08-01
Completed
105
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer
2001-08-01
Completed
63
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer
2002-08-01
2011-01-01
Completed
1,742
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Universitätsklinikum Magdeburg" #1 sponsor was "University of Ulm" with 11 trials, followed by "German CLL Study Group" with 9 trials
sponsored, "Boehringer Ingelheim" with 5 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials sponsored and "AGO Study Group"
with 5 trials sponsored. Other sponsors include 117 different institutions and
companies that sponsored additional 96 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Magdeburg"
#1 collaborator was "Deutsche Kinderkrebsstiftung" with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Cancer Trials Ireland" with 2 trials as a collaborator. Other collaborators include 80 different institutions and companies that were
collaborators in the rest 83 trials.
Clinical Trials Conditions at Universitätsklinikum Magdeburg
According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Magdeburg" are
"Lymphoma" (8 trials), "Chronic Lymphocytic Leukemia" (7 trials), "Acute Myeloid Leukemia" (6 trials), "Ovarian Cancer" (6 trials) and "Acute Myeloid Leukemia (AML)" (4 trials). Many other conditions were trialed in "Universitätsklinikum Magdeburg" in a lesser frequency.
Clinical Trials Intervention Types at Universitätsklinikum Magdeburg
Most popular intervention types in "Universitätsklinikum Magdeburg" are "Drug" (106 trials), "Biological" (24 trials), "Device" (21 trials), "Radiation" (17 trials) and "Procedure" (15 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (21 trials), "cyclophosphamide" (12 trials), "radiation therapy" (11 trials), "doxorubicin hydrochloride" (9 trials) and "filgrastim" (9 trials). Other intervention names were less common.
Clinical Trials Genders at Universitätsklinikum Magdeburg
The vast majority of trials in "Universitätsklinikum Magdeburg" are
139 trials for "All" genders, 11 trials for "Female" genders and 6 trials for "Male" genders.
Clinical Trials Status at Universitätsklinikum Magdeburg
Currently, there are NaN active trials in "Universitätsklinikum Magdeburg".
undefined are not yet recruiting,
25 are recruiting,
17 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 84 completed trials in Universitätsklinikum Magdeburg,
undefined suspended trials,
and 18 terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsklinikum Magdeburg, 7 "Phase 1"
clinical trials were conducted, 47 "Phase 2" clinical
trials and 64 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 16 trials that are defined as “Not Applicable".
Departments of Universitätsklinikum Magdeburg
Universitätsklinikum Magdeburg has several departments that took part in Clinical trials: "Department of Urology University Hospital Otto-von-Guericke-University Magdeburg" - 3 trials, "Otto von Guericke University Magdeburg, Department of Pediatrics" - 2 trials
Departments List